(19)
(11) EP 2 857 401 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.11.2019 Bulletin 2019/47

(45) Mention of the grant of the patent:
18.09.2019 Bulletin 2019/38

(21) Application number: 13796357.5

(22) Date of filing: 30.05.2013
(51) International Patent Classification (IPC): 
C07D 211/60(2006.01)
A61K 31/439(2006.01)
A61K 31/4545(2006.01)
A61K 45/06(2006.01)
A61K 31/4162(2006.01)
A61K 31/43(2006.01)
A61P 43/00(2006.01)
C07D 471/08(2006.01)
A61K 31/444(2006.01)
A61K 31/5377(2006.01)
A61K 31/407(2006.01)
A61K 31/427(2006.01)
A61P 31/04(2006.01)
(86) International application number:
PCT/JP2013/064971
(87) International publication number:
WO 2013/180197 (05.12.2013 Gazette 2013/49)

(54)

NOVEL ß-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME

NEUARTIGER ß-LACTAMASEHEMMER UND VERFAHREN ZUR HERSTELLUNG DAVON

NOUVEL INHIBITEUR DE ß-LACTAMASE ET PROCÉDÉ DE PRODUCTION DE CELUI-CI


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.05.2012 JP 2012122603

(43) Date of publication of application:
08.04.2015 Bulletin 2015/15

(73) Proprietor: Meiji Seika Pharma Co., Ltd.
Tokyo 104-8002 (JP)

(72) Inventors:
  • ABE, Takao
    Yokohama-shi Kanagawa 222-8567 (JP)
  • FURUUCHI, Takeshi
    Yokohama-shi Kanagawa 222-8567 (JP)
  • SAKAMAKI, Yoshiaki
    Yokohama-shi Kanagawa 222-8567 (JP)
  • INAMURA, Seiichi
    Yokohama-shi Kanagawa 222-8567 (JP)
  • MORINAKA, Akihiro
    Yokohama-shi Kanagawa 222-8567 (JP)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)


(56) References cited: : 
WO-A1-2011/042560
WO-A1-2013/030733
WO-A1-2013/149121
WO-A1-2014/091268
WO-A1-2014/135932
WO-A2-2010/126820
JP-A- 2005 518 333
JP-A- 2010 539 147
JP-A- 2011 518 871
US-A1- 2004 157 826
WO-A1-2012/172368
WO-A1-2013/030735
WO-A1-2014/033560
WO-A1-2014/135931
WO-A2-2009/091856
JP-A- 2004 505 088
JP-A- 2005 523 897
JP-A- 2011 510 012
JP-A- 2012 504 593
   
  • MANGION, I.K. ET AL.: 'A concise synthesis of a P-lactamase inhibitor' ORGANIC LETTERS vol. 13, no. 20, 2011, pages 5480 - 5483, XP055033007
  • BROWN, L.D. ET AL.: 'Active derivatives of penicillin' APPLIED MICROBIOLOGY vol. 17, no. 3, 1969, pages 339 - 343, XP055179325
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).